Abstract:Osteoclasts are myeloid lineage-derived bone-resorbing cells of hematopoietic origin. They differentiate from myeloid precursors through a complex regulation process where the differentiation of preosteoclasts is followed by intercellular fusion to generate large multinucleated cells. Under physiological conditions, osteoclastogenesis is primarily directed by interactions between CSF-1R and macrophage colony-stimulating factor (M-CSF, CSF-1), receptor activator of nuclear factor NF-κB (RANK) and RANK ligand (RANKL), as well as adhesion receptors (e.g., integrins) and their ligands. Osteoclasts play a central role in physiological and pathological bone resorption and are also required for excessive bone loss during osteoporosis, inflammatory bone and joint diseases (such as rheumatoid arthritis) and cancer cell-induced osteolysis. Due to the major role of osteoclasts in these diseases the better understanding of their intracellular signaling pathways can lead to the identification of potential novel therapeutic targets. Non-receptor tyrosine kinases and lipid kinases play major roles in osteoclasts and small-molecule kinase inhibitors are emerging new therapeutics in diseases with pathological bone loss. During the last few years, we and others have shown that certain lipid (such as phosphoinositide 3-kinases PI3Kβ and PI3Kδ) and tyrosine (Src−family and Syk) kinases play a critical role in osteoclast differentiation and function in humans and mice. Some of these signaling pathways shows similarity to immunoreceptor-like receptor signaling and involves important other enzymes (e.g., PLCγ2) and adapter proteins (such as the ITAM−bearing adapters DAP12 and the Fc-receptor γ-chain). Here, we review recently identified osteoclast signaling pathways and their role in osteoclast differentiation and function as well as pathological bone loss associated with osteolytic tumors of the bone. A better understanding of osteoclast signaling may facilitate the design of novel and more efficient therapies for pathological bone resorption and osteolytic skeletal metastasis formation.

Signaling networks that control the lineage commitment and differentiation of bone cells

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Wnt Signaling:Essential Roles in Osteoblast Differentiation,bone Metabolism and Therapeutic Implications for Bone and Skeletal Disorders

Signaling Pathways Governing Osteoblast Proliferation, Differentiation and Function.

Regulation of bone homeostasis: signaling pathways and therapeutic targets.

[The Study of Signal Pathway Regulating the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells].

TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease

Osteoblast Differentiation and Signaling: Established Concepts and Emerging Topics

Osteoclast Differentiation and Gene Regulation

The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease

MicroRNAs Regulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells (Review)

Regulation and Role of Transcription Factors in Osteogenesis

Osteoblastogenesis Regulation Signals in Bone Remodeling

Regulatory cellular and molecular networks in the bone microenvironment during aging

Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways

Epigenetic regulators controlling osteogenic lineage commitment and bone formation

Tgf-Beta And Bmp Signaling In Osteoblast Differentiation And Bone Formation

Regulation of Osteoblast Differentiation by Cytokine Networks

Osteoclast Signal Transduction During Bone Metastasis Formation

Signaling Mechanism of Osteoblastic Differentiation of Bone Morphogenetic Proteins

The Function of Wnt Ligands on Osteocyte and Bone Remodeling